Perrigo Financial Ratios
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Perrigo ratio analysis
Perrigo earned a net margin of -33.5% in FY 2025, down from -3.9% a year earlier. Gross margin was 35.1% compared with a median of 36.6% over the prior 9 years. Return on equity reached -48.6%, meaning Perrigo generated -0.49 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 1.24 versus 0.84 the year before, and the current ratio was 2.76. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Perrigo financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | — | — | — | 46.69 | 44.55 | 103.76 | — |
| Price / sales | 0.45 | 0.82 | 0.94 | 1.03 | 1.26 | 1.49 | 1.76 | 1.23 | 2.51 | 2.26 |
| Price / book | 0.66 | 0.83 | 0.91 | 0.95 | 1.01 | 1.08 | 1.17 | 1.03 | 2.01 | 2.00 |
| Gross margin | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% | 36.6% | 37.0% | 38.7% | 40.0% | 38.9% |
| Operating margin | -26.4% | 2.6% | 3.3% | 1.8% | 9.9% | 6.5% | 4.5% | 5.0% | 12.1% | -37.9% |
| Net margin | -33.5% | -3.9% | -0.3% | -3.2% | -1.7% | -4.0% | 3.8% | 2.8% | 2.4% | -76.0% |
| Free cash flow margin | 3.4% | 5.6% | 6.5% | 4.7% | 0.1% | 11.4% | 6.5% | 10.4% | 12.3% | 10.4% |
| Return on equity (ROE) | -48.6% | -4.0% | -0.3% | -2.9% | -1.3% | -2.9% | 2.5% | 2.3% | 1.9% | -67.4% |
| Return on assets (ROA) | -16.7% | -1.8% | -0.1% | -1.3% | -0.7% | -1.4% | 1.3% | 1.2% | 1.0% | -28.9% |
| Debt / equity | 1.24 | 0.84 | 0.85 | 0.85 | 0.68 | 0.63 | 0.58 | 0.57 | 0.54 | 0.97 |
| Current ratio | 2.76 | 2.38 | 1.79 | 2.44 | 2.43 | 2.27 | 2.04 | 1.89 | 1.96 | 1.53 |
| Revenue growth | -2.8% | -6.1% | 4.6% | 7.6% | 1.2% | 5.6% | -18.2% | -4.3% | -6.3% | 24.9% |
| EPS growth | — | — | — | — | — | -211.2% | 12.6% | 13.1% | — | -2,987.6% |